GlassScriptPhysician profile
John G Calaitges
NPI 1932191459
$3,014.63
in general payments reported to CMS, 2019-2025
22 companies · $138 in 2025
The $138 reported for 2025 was less than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $574 · 2020: $108 · 2021: $302 · 2022: $371 · 2023: $924 · 2024: $597 · 2025: $138.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,659.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $791.29 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Medtronic, INC. | $518.34 | 2021-2025 | Endurant Iis, Valiant Captivia |
| Lemaitre Vascular, INC. | $267.06 | 2023 | Artegraft Vascular Graft, Cardiocel |
| Smith+Nephew, INC. | $228.49 | 2019-2025 | Collagenase Santyl |
| Sanara Medtech INC. | $224.80 | 2021-2024 | Celleraterx |
| Penumbra, INC. | $153.32 | 2022 | |
| Medtronic Vascular, INC. | $127.66 | 2019-2020 | |
| W. L. Gore & Associates, INC. | $95.00 | 2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Bard Peripheral Vascular, INC. | $89.67 | 2019-2023 | Rotarexs 6 F X 135 Cm |
| Allergan, INC. | $78.12 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $72.54 | 2022 | |
| Inari Medical, INC. | $66.03 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Paratek Pharmaceuticals, INC. | $62.99 | 2024 | Nuzyra |
| Medline Industries LP | $59.50 | 2019-2023 | |
| Organogenesis INC. | $37.54 | 2023-2024 | Puraply, Puraply Am |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Solventum Corporation | $30.71 | 2024 | Activ.A.C. |
| Convatec INC. | $26.56 | 2023 | |
| Aroa Biosurgery Incorporated | $20.07 | 2019 | |
| Tactile Systems Technology INC | $19.21 | 2021 | |
| Philips North America LLC | $17.25 | 2021 | |
| Kerecis Limited | $14.85 | 2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide, Kerecis Omega3 Marigen |
| Cashflow Solutions, LLC | $13.63 | 2023 | Pcd-51 731a (US) - White, Pcd-52 737a (US) White, Lympha Press Optimal Plus(US) Bt |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Calaitges listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.